1-3 of 3
Poulikos I. Poulikakos
Close
Sort by
Journal Articles

Triple MAPK Inhibition Salvaged a Relapsed Post BCMA CAR-T Cell Therapy in Multiple Myeloma Patient with BRAF V600E Dominant Clone

Muhammad Elnaggar, David T. Melnekoff, Sarita Agte, Christos Adamopoulos, Mark M. Stevens, Violetta Leshchenko, Katerina Kappes, Daniel Verina, Poulikos I. Poulikakos, Sundar Jagannath, Samir Parekh
Journal: Blood
Blood (2021) 138 (Supplement 1): 4720.
https://doi.org/10.1182/blood-2021-151512
Published: 2021
Journal Articles

Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis

Clinical Trials & Observations Brief Report
Rikhia Chakraborty, Thomas M. Burke, Oliver A. Hampton, Daniel J. Zinn, Karen Phaik Har Lim, Harshal Abhyankar, Brooks Scull, Vijetha Kumar, Nipun Kakkar, David A. Wheeler, Angshumoy Roy, Poulikos I. Poulikakos, Miriam Merad, Kenneth L. McClain, D. Williams Parsons, Carl E. Allen
Journal: Blood
Blood (2016) 128 (21): 2533–2537.
https://doi.org/10.1182/blood-2016-08-733790
Published: 2016
Includes: Supplemental data
Journal Articles

Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis

Rikhia Chakraborty, Oliver A. Hampton, Xiaoyun Shen, Stephen J. Simko, Albert Shih, Harshal Abhyankar, Karen Phaik Har Lim, Kyle R. Covington, Lisa Trevino, Ninad Dewal, Donna M. Muzny, Harshavardhan Doddapaneni, Jianhong Hu, Linghua Wang, Philip J. Lupo, M. John Hicks, Diana L. Bonilla, Karen C. Dwyer, Marie-Luise Berres, Poulikos I. Poulikakos, Miriam Merad, Kenneth L. McClain, David A. Wheeler, Carl E. Allen, D. Williams Parsons
Journal: Blood
Blood (2014) 124 (19): 3007–3015.
https://doi.org/10.1182/blood-2014-05-577825
Published: 2014
Includes: Supplemental data